Applied Genetic Technologies reported 509K in Interest Expense on Debt for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Applied Genetic Technologies AGTC:US 509K 179K
Biogen BIIB:US $ 56.4M 8.3M
Cti Biopharma CTIC:US $ 0.18M 0.02M
Gilead Sciences GILD:US $ 256M 1M
Insmed INSM:US $ 10.32M 2.76M
Intercept Pharmaceuticals ICPT:US $ 12.59M 0.17M
Regeneron Pharmaceuticals REGN:US $ 14.4M 0.2M
Rigel Pharmaceuticals RIGL:US $ 1.76M 1.27M